Accelerate to discover

Back to filter

Related topics

Rapid, Quantitative CEST Imaging with MRI Fingerprinting

Bruker Biospin

Apr 16, 2019

With applications spanning almost any disease area, from cancer, stroke, through to cardiac metabolism disorders, this...

Monitoring cancer treatments with immuno-PET webinar

Bruker Biospin

Mar 8, 2019

In this webinar, Dr Gabriela Kramer-Marek, Team Leader in Preclinical Molecular Imaging The Institute of Cancer...

Izon qEV - The fastest & most effective Exosome isolation

IZON

Mar 6, 2019

Extracellular  vesicles  (EVs)  are  prevalent  in biological  fluids  and  are  of  great  interest  to researchers ...

Etaluma can now offer integrated tablet for LS460/560/620 scopes

Etaluma

Jan 25, 2019

Based on the customer requests of tablet mount configuration for sterile picking in the hood, Etaluma can now offer the...

Apr 20, 2019

Spectral data analysis webinar recording - Cytek flow cytometer and De Novo Software

Cytek Biosciences

Jan 17, 2019

Cytek Biosciences and De Novo Software are proud to announce a collaboration that allows you to work with your spectral...

IncuCyte webinar recording: CAR T-cell therapy, frontiers in cancer Immunotherapy

Sartorius

Jan 11, 2019

The success of immune checkpoint blockade adds new therapeutic category to Cancers are the most heterogenous group of...

Cytek Aurora spectral flow cytometer - say hello to a new reality

Cytek Biosciences

Jan 7, 2019

A prodigy that takes flow cytometry to the next level of performance and flexibility. With up to four lasers, three...

Apr 20, 2019

Bioflux webinar: Blockade of CD62L inhibits CLL cell interaction with vascular endothelium

Fluxion Biosciences

Nov 22, 2018

CD62L (L-selectin) is a key adhesion molecule that promotes cell tethering and rolling along the vascular endothelium...

Show all topics (10)

The evaluation of three digital PCR platforms for residual disease in chronic myeloid leukemia

Oct 11, 2016

Thursday, October 13, 2016, 5 pm CEST

Mary Alikian, Ph.D., Imperial Molecular Pathology laboratory and the Department of Haematology at Hammersmith Hospital, Imperial College London

The BCR-ABL1 fusion gene sequence is used to help diagnose and monitor treatment and recurrence for chronic myelogenous leukemia (CML). In fact, between 90-95% of diagnosed CML cases are BCR-ABL1-positive. While reverse transcription quantitative PCR (RT-qPCR) is the gold standard strategy for monitoring BCR-ABL1 transcripts, there can often be challenges with reproducibility due to the technology and workflow. Reverse-Transcription Digital PCR (RT-dPCR) is an adaptation of this method that could provide the robust and standardized workflow needed for patient stratification. In this webinar, Dr. Mary Alikian at Hammersmith Hospital, Imperial College London, discussed her team’s comparison of three different available dPCR platforms (ThermoFisher Scientific’s QuantStudio 3D System, Bio-Rad’s QX200 System and RainDance’s RainDrop System) and investigation of whether they could be applied to a clinical research setting to quantify BCR-ABL1 transcripts in CML patients. The team determined that only the RainDrop System was able to detect and quantitatively measure BCR-ABL1 transcripts in the <0.001% range at a level higher than the false positive rate in the control patient groups.

Register now

Technical breakthrough
Webinar

Related technologies: Digital PCR

Get more info

Regina Fillerová

Field application specialist

Regina

Fillerová

+420 731 127 718

Send Message

Brand profile

RainDance Technologies

RainDance company’s ultra-sensitive genomic tools enable research of novel non-invasive liquid biopsy applications that should result in more accurate, reliable, cost-effective, and early detection of cancer and other inherited and infectious diseases.

Related products

Capable of generating more than a billion reactions in a single day, the RainDrop system surpasses all existing technologies and establishes a new performance standard in sensitivity, quantitation and multiplexing.

show detail

We supply and support Life-Science Technologies in the territory of Central and Eastern Europe.

Czech Republic

Slovakia

Hungary

Poland

Croatia

Slovenia

Serbia

Romania

Bulgaria

Latvia

Lithuania

Estonia

Russia

Ukraine

Belarus

Turkey